[Progress of therapeutic agents for asthma--3) Trends in the development of leukotriene inhibitory agents].
Ohata
K
K
Kohno
S
S
D015126:8,11,14-Eicosatrienoic Acid / Q000494:pharmacology / Q000627:therapeutic use* / Q000031:analogs & derivatives; D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000378:metabolism; D002867:Chromones / Q000494:pharmacology / Q000627:therapeutic use*; D004285:Dogs; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use*; D006168:Guinea Pigs; D051381:Rats; D018077:Receptors, Leukotriene; D011982:Receptors, Prostaglandin / Q000037:antagonists & inhibitors*; D013189:SRS-A / Q000096:biosynthesis*
D002867:Chromones; D005231:Fatty Acids, Unsaturated; D018077:Receptors, Leukotriene; D011982:Receptors, Prostaglandin; D013189:SRS-A; C006312:FPL 55712; D015126:8,11,14-Eicosatrienoic Acid; C010944:mead acid